FOXO1 and alveolar rhabdomyosarcoma: Since there are also ARMS cases that are fusion-negative and have a better outcome than fusion-positive cases, it was more recently recommended that RMS should be classified into fusion-positive (PAX3–FOXO1 and PAX7–FOXO1) and fusion-negative tumors [7].